Table 1.
Characteristics of hospitalized COVID‐19 patients by vital status
| Variable, n (%)* | Alive (n = 1294)** | Deceased (n = 304)** | P value |
|---|---|---|---|
| Age, mean (SD) | 62.9 (16.5) | 81.5 (10.5) | < 0.001 |
| Sex (male) | 682 (52.7) | 163 (53.6) | 0.774 |
| CCI, median [P25 – P75] | 2 [1–4] | 6 [4–7] | < 0.001 |
| Any previous comorbidity | 879 (67.9) | 275 (90.5) | < 0.001 |
| Diabetes | 232 (17.9) | 87 (28.6) | < 0.001 |
| Hypertension | 585 (45.2) | 226 (74.3) | < 0.001 |
| Vascular disease (MI, CVA, PVD) | 195 (15.1) | 103 (33.9) | < 0.001 |
| Active cancer | 60 (4.6) | 35 (11.5) | < 0.001 |
| CRD | 185 (14.3) | 50 (16.4) | 0.341 |
| ICU | 133 (10.3) | 55 (18.1) | < 0.001 |
| Days ICU, median [P25 – P75] | 10 [5–27] | 14 [9–20] | 0.419 |
| Days hospitalization, median [P25 – P75] | 6 [3–10] | 4 [2–9] | < 0.001 |
| Thromboembolic events | 66 (5.1) | 19 (6.3) | 0.422 |
| Hemorrhagic events | 28 (2.2) | 10 (3.3) | 0.246 |
|
No previous AC or AP AC AP |
996 (77.0) 100 (7.7) 198 (15.3) |
139 (45.7) 55 (18.1) 110 (36.2) |
< 0.001 |